Prilosec and Hypermagnesaemia - a phase IV clinical study of FDA data

Summary:

Hypermagnesaemia is reported as a side effect among people who take Prilosec (omeprazole), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Neurontin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hypermagnesaemia when taking Prilosec. It is created by eHealthMe based on reports of 171,578 people who have side effects when taking Prilosec from the FDA, and is updated regularly.

What is Prilosec?

Prilosec has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 175,285 Prilosec users. Check the latest studies of Prilosec.

What is Hypermagnesaemia?

Hypermagnesaemia (an electrolyte disturbance in which there is an abnormally elevated level of magnesium in the blood) is found to be associated with 140 drugs and 203 conditions by eHealthMe. Check the latest studies of Hypermagnesaemia.

On Jul, 30, 2026

171,578 people reported to have side effects when taking Prilosec.
Among them, 13 people (0.01%) have Hypermagnesaemia.

Among these 13 people:

How long have people been on Prilosec when they have Hypermagnesaemia? *

What is the gender of people who have Hypermagnesaemia when taking Prilosec? *

female: 30.77 %
male: 69.23 %

What is the age of people who have Hypermagnesaemia when taking Prilosec? *

What are other drugs people take besides Prilosec? *

What are other side effects people have besides Hypermagnesaemia? *

Oedema Peripheral (superficial swelling): 9 people, 69.23%
Injury: 9 people, 69.23%
Depression: 9 people, 69.23%
Cellulitis (infection under the skin): 9 people, 69.23%
Haematuria (presence of blood in urine): 9 people, 69.23%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 69.23%
Erection Problems: 8 people, 61.54%
Decreased Interest: 8 people, 61.54%
Diabetic Nephropathy (diabetic kidney disease): 8 people, 61.54%
Dyslipidaemia (abnormal amount of lipids): 8 people, 61.54%

What are the existing conditions these people have? *

Bone Disorder: 8 people, 61.54%
Multiple Myeloma (cancer of the plasma cells): 8 people, 61.54%
Constipation: 2 people, 15.38%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 15.38%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Asthma: 1 person, 7.69%
Blood Pressure Abnormal: 1 person, 7.69%
Body Temperature Increased: 1 person, 7.69%
Cough: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Prilosec and have Hypermagnesaemia?

- Check whether Hypermagnesaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prilosec:

Prilosec (175,285 reports)

Browse all side effects of Prilosec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypermagnesaemia:

Hypermagnesaemia (140 drugs)

Browse all the conditions that are associated with Hypermagnesaemia:

Hypermagnesaemia (203 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omeprazole (the active ingredients of Prilosec) and Prilosec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.